GlassScriptPhysician profile
Taylor Ballard
NPI 1487185252
$3,271.63
in general payments reported to CMS, 2019-2025
12 companies · $463 in 2025
The $463 reported for 2025 was more than what 78% of Pediatric Surgery providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.13 · 2021: $165 · 2022: $104 · 2023: $235 · 2024: $2,268 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,751 · Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,751.22 |
| Food and Beverage | $1,214.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,211.49 | 2023-2024 | |
| Intuitive Surgical, INC. | $378.34 | 2025 | |
| Medtronic, INC. | $219.64 | 2021-2025 | Ligasure, Signia |
| Baxter Healthcare | $124.22 | 2021 | |
| Davol INC. | $104.25 | 2022 | |
| Karl Storz Endoscopy-America | $83.50 | 2023 | N.A. |
| Avanos Medical | $39.51 | 2023-2024 | Mic-Key |
| Asensus Surgical, INC. | $31.49 | 2024 | Senhance |
| Stryker Corporation | $26.77 | 2024 | Stryker |
| Tesaro, INC. | $21.68 | 2019 | |
| Lilly USA, LLC | $15.45 | 2019 | |
| Smith+Nephew, INC. | $15.29 | 2023 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.